InvestorsHub Logo
Followers 839
Posts 120509
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 533

Wednesday, 11/01/2017 3:28:15 PM

Wednesday, November 01, 2017 3:28:15 PM

Post# of 625
ICPT stopped development of INT-767, the backup FXR agonist. It’s presumably no better than Ocaliva.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”